Save time and money on the road to breakthroughs.
Globally decentralized biomarker testing.
Our advanced molecular technology, Aspyre®, was designed to overcome the limitations of PCR and NGS technologies, breaking down the barriers to decentralized biomarker testing.
The first research use only (RUO) application of the Aspyre technology, Aspyre Lung Reagents enable fast, simple and reliable detection of targetable biomarkers for use in non-small cell lung cancer (NSCLC) research.
Simple, fast, reliable biomarker testing on samples you control.
Aspyre Lung Reagents let you run rapid, localized trial screening on samples you control, on existing qPCR platforms. Make more confident decisions at every stage of the drug development process with ultra-sensitive biomarker detection that seamlessly integrates into existing lab workflows.
Local, cost-effective biomarker testing in any lab.
Aspyre Lung Reagents simultaneously analyze DNA and RNA from blood or tissue in a single assay. Not only do they help biopharma companies bring new therapies to market, they help you maximize post-market uptake of those therapies by identifying eligible patients in a fraction of the time.
Aspyre Lung Reagents
Want to bring Aspyre Lung into your own laboratory for research use only? Aspyre Lung Reagents enable fast, simple, reliable detection of targetable biomarkers for use in NSCLC research.